193 related articles for article (PubMed ID: 36359851)
1. Alternatively Spliced Landscape of PPARγ mRNA in Podocytes Is Distinct from Adipose Tissue.
Bryant C; Webb A; Banks AS; Chandler D; Govindarajan R; Agrawal S
Cells; 2022 Nov; 11(21):. PubMed ID: 36359851
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
Vidal-Puig AJ; Considine RV; Jimenez-Liñan M; Werman A; Pories WJ; Caro JF; Flier JS
J Clin Invest; 1997 May; 99(10):2416-22. PubMed ID: 9153284
[TBL] [Abstract][Full Text] [Related]
3. The protective role of peroxisome proliferator-activated receptor gamma in lipotoxic podocytes.
Carrasco AG; Izquierdo-Lahuerta A; Valverde ÁM; Ni L; Flores-Salguero E; Coward RJ; Medina-Gómez G
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Jul; 1868(7):159329. PubMed ID: 37156296
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN.
Henique C; Bollee G; Lenoir O; Dhaun N; Camus M; Chipont A; Flosseau K; Mandet C; Yamamoto M; Karras A; Thervet E; Bruneval P; Nochy D; Mesnard L; Tharaux PL
J Am Soc Nephrol; 2016 Jan; 27(1):172-88. PubMed ID: 25999406
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.
Zhou Z; Wan J; Hou X; Geng J; Li X; Bai X
Cell Death Dis; 2017 Mar; 8(3):e2658. PubMed ID: 28277542
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of PPARγ agonist in acute nephrotic syndrome.
Zuo Y; Yang HC; Potthoff SA; Najafian B; Kon V; Ma LJ; Fogo AB
Nephrol Dial Transplant; 2012 Jan; 27(1):174-81. PubMed ID: 21565943
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.
Yang HC; Ma LJ; Ma J; Fogo AB
Kidney Int; 2006 May; 69(10):1756-64. PubMed ID: 16598202
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.
Simon MF; Daviaud D; Pradère JP; Grès S; Guigné C; Wabitsch M; Chun J; Valet P; Saulnier-Blache JS
J Biol Chem; 2005 Apr; 280(15):14656-62. PubMed ID: 15710620
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil Prevents Podocyte Injury
Sonneveld R; Hoenderop JG; Isidori AM; Henique C; Dijkman HB; Berden JH; Tharaux PL; van der Vlag J; Nijenhuis T
J Am Soc Nephrol; 2017 May; 28(5):1491-1505. PubMed ID: 27895156
[TBL] [Abstract][Full Text] [Related]
10. Fn14 in podocytes and proteinuric kidney disease.
Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
[TBL] [Abstract][Full Text] [Related]
11. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression.
Yu S; Matsusue K; Kashireddy P; Cao WQ; Yeldandi V; Yeldandi AV; Rao MS; Gonzalez FJ; Reddy JK
J Biol Chem; 2003 Jan; 278(1):498-505. PubMed ID: 12401792
[TBL] [Abstract][Full Text] [Related]
12. Expression and cDNA cloning of porcine peroxisome proliferator-activated receptor gamma (PPARgamma).
Houseknecht KL; Bidwell CA; Portocarrero CP; Spurlock ME
Gene; 1998 Dec; 225(1-2):89-96. PubMed ID: 9931452
[TBL] [Abstract][Full Text] [Related]
13. Hemicentin 1 influences podocyte dynamic changes in glomerular diseases.
Toffoli B; Zennaro C; Winkler C; Giordano Attianese GMP; Bernardi S; Carraro M; Gilardi F; Desvergne B
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1154-F1165. PubMed ID: 29488390
[TBL] [Abstract][Full Text] [Related]
14. Regulation of small ubiquitin-like modifier-1, nuclear receptor coreceptor, histone deacetylase 3, and peroxisome proliferator-activated receptor-γ in human adipose tissue.
Finlin BS; Bodles-Brakhop AM; Yao-Borengasser A; Zhu B; Starnes CP; McGehee RE; Peterson CA; Kern PA; Rasouli N
Metab Syndr Relat Disord; 2012 Aug; 10(4):312-7. PubMed ID: 22651256
[TBL] [Abstract][Full Text] [Related]
15. Zhen-wu-tang protects against podocyte injury in rats with IgA nephropathy via PPARγ/NF-κB pathway.
Liu B; He Y; Lu R; Zhou J; Bai L; Zhang P; Ye S; Wu J; Liang C; Zhou Y; Zhou J
Biomed Pharmacother; 2018 May; 101():635-647. PubMed ID: 29518610
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPARγ.
Zhu C; Huang S; Yuan Y; Ding G; Chen R; Liu B; Yang T; Zhang A
Am J Pathol; 2011 May; 178(5):2020-31. PubMed ID: 21514419
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma (PPARγ) in yellow catfish Pelteobagrus fulvidraco: molecular characterization, mRNA expression and transcriptional regulation by insulin in vivo and in vitro.
Zheng JL; Zhuo MQ; Luo Z; Pan YX; Song YF; Huang C; Zhu QL; Hu W; Chen QL
Gen Comp Endocrinol; 2015 Feb; 212():51-62. PubMed ID: 25637673
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
19. DHL-HisZn, a novel antioxidant, enhances adipogenic differentiation and antioxidative response in adipose-derived stem cells.
Chen CC; Hsu LW; Nakano T; Huang KT; Chen KD; Lai CY; Goto S; Chen CL
Biomed Pharmacother; 2016 Dec; 84():1601-1609. PubMed ID: 27825800
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesis.
Kast-Woelbern HR; Dana SL; Cesario RM; Sun L; de Grandpre LY; Brooks ME; Osburn DL; Reifel-Miller A; Klausing K; Leibowitz MD
J Biol Chem; 2004 Jun; 279(23):23908-15. PubMed ID: 15073165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
